Outset Medical Operating Income 2019-2023 | OM

Outset Medical operating income from 2019 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Outset Medical Annual Operating Income
(Millions of US $)
2023 $-170
2022 $-161
2021 $-131
2020 $-117
2019 $-70
2018 $-47
Outset Medical Quarterly Operating Income
(Millions of US $)
2023-12-31 $-37
2023-09-30 $-45
2023-06-30 $-43
2023-03-31 $-43
2022-12-31 $-40
2022-09-30 $-41
2022-06-30 $-44
2022-03-31 $-36
2021-12-31 $-41
2021-09-30 $-30
2021-06-30 $-30
2021-03-31 $-30
2020-12-31 $-32
2020-09-30 $-41
2020-06-30 $-25
2020-03-31 $-20
2019-12-31
2019-09-30 $-18
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.131B $0.130B
Outset Medical Inc. is a medical technology company. Its Tablo(R) Hemodialysis System represents technological advancement enabling novel, transformational dialysis care in acute and home settings. Outset Medical Inc. is based in CA, United States.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $34.790B 19.11
Inspire Medical Systems (INSP) United States $7.322B 0.00
10x Genomics (TXG) United States $3.489B 0.00
IRhythm Technologies (IRTC) United States $3.410B 0.00
Axonics (AXNX) United States $3.396B 0.00
Enovis (ENOV) United States $3.029B 23.01
Azenta (AZTA) United States $2.925B 238.46
Olink Holding AB (publ) (OLK) Sweden $2.864B 0.00
Hims & Hers Health (HIMS) United States $2.685B 0.00
Privia Health (PRVA) United States $2.183B 96.84
Schrodinger (SDGR) United States $1.763B 0.00
Omnicell (OMCL) United States $1.231B 30.12
Phreesia (PHR) United States $1.169B 0.00
Definitive Healthcare (DH) United States $0.817B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.783B 0.00
Standard BioTools (LAB) United States $0.719B 0.00
Fulgent Genetics (FLGT) United States $0.608B 0.00
Talkspace (TALK) United States $0.519B 0.00
Health Catalyst (HCAT) United States $0.367B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.333B 0.00
Clover Health Investments (CLOV) United States $0.312B 0.00
Pulmonx (LUNG) United States $0.293B 0.00
P3 Health Partners (PIII) United States $0.170B 0.00
Butterfly Network (BFLY) United States $0.162B 0.00
American Well (AMWL) United States $0.148B 0.00
MSP Recovery (LIFW) United States $0.139B 0.00
Augmedix (AUGX) United States $0.133B 0.00
TruBridge (TBRG) United States $0.116B 4.94
111 (YI) China $0.087B 0.00
Future Health ESG (FHLT) United States $0.073B 0.00
SHL Telemedicine (SHLT) Israel $0.071B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
EUDA Health Holdings (EUDA) Singapore $0.047B 0.00
Movano (MOVE) United States $0.044B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.034B 0.00
Akili (AKLI) United States $0.031B 0.00
Bullfrog AI Holdings (BFRG) United States $0.025B 0.00
Cue Health (HLTH) United States $0.022B 0.00
CareCloud (CCLD) United States $0.018B 0.00
Streamline Health Solutions (STRM) United States $0.018B 0.00
ETAO (ETAO) United States $0.016B 0.00
Strata Skin Sciences (SSKN) United States $0.014B 0.00
Biotricity (BTCY) United States $0.013B 0.00
Transgenomic (PRPO) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00